Physician profile
Ulka Sachdev
NPI 1669585808
$3,991.90
in general payments reported to CMS, 2019-2025
7 companies · $2,600 in 2025
The $2,600 reported for 2025 was more than what 75% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.92 · 2021: $101 · 2022: $283 · 2023: $761 · 2024: $178 · 2025: $2,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,841 · Travel and Lodging: $1,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,841.41 |
| Travel and Lodging | $1,697.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,367.88 | 2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $463.85 | 2021-2023 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis |
| Cook Medical LLC | $399.84 | 2019-2025 | Zenith Spiral-Z, Zilver Ptx |
| Medtronic, INC. | $272.94 | 2022-2024 | Abre |
| Bard Peripheral Vascular, INC. | $200.36 | 2023 | Venclose Maven Catheter |
| Inari Medical, INC. | $197.84 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $89.19 | 2025 | Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ulka Sachdev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.